| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 25.777 | 42.369 | 41.369 | 49.329 | 55.276 | 49.131 | 64.397 | 73.806 |
| Total Income - EUR | 167 | 0 | 35.847 | 42.370 | 41.641 | 49.329 | 55.277 | 49.132 | 64.398 | 73.812 |
| Total Expenses - EUR | 0 | 134 | 38.658 | 41.458 | 57.694 | 42.720 | 41.662 | 42.357 | 48.098 | 58.851 |
| Gross Profit/Loss - EUR | 167 | -134 | -2.811 | 912 | -16.053 | 6.609 | 13.614 | 6.774 | 16.300 | 14.961 |
| Net Profit/Loss - EUR | 162 | -134 | -3.069 | 490 | -16.466 | 6.315 | 13.088 | 6.283 | 15.677 | 13.298 |
| Employees | 0 | 0 | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Andariamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 11.023 | 16.450 | 71.223 | 64.802 | 58.854 | 53.094 | 50.954 | 49.238 | 48.798 |
| Current Assets | 1.546 | 132 | 1.967 | 4.238 | 4.040 | 4.915 | 7.022 | 7.207 | 13.927 | 12.764 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 693 | 0 |
| Receivables | 0 | 0 | 810 | 2.673 | 3.873 | 4.274 | 5.128 | 6.438 | 12.472 | 11.891 |
| Cash | 1.546 | 132 | 1.157 | 1.565 | 167 | 641 | 1.894 | 770 | 763 | 873 |
| Shareholders Funds | -6.351 | -6.327 | -9.289 | -10.777 | -28.092 | -21.244 | -7.685 | -1.426 | 14.255 | 27.473 |
| Social Capital | 0 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 7.898 | 17.482 | 27.717 | 86.256 | 96.985 | 85.039 | 67.901 | 59.603 | 48.927 | 34.088 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Andariamed S.r.l.